首页 > 最新文献

Monaldi Archives for Chest Disease最新文献

英文 中文
Hematological and clinical profiling of chronic obstructive pulmonary disease: a comprehensive study. 慢性阻塞性肺病的血液学和临床特征:一项综合研究。
IF 0.8 Q4 RESPIRATORY SYSTEM Pub Date : 2025-10-14 Epub Date: 2024-09-30 DOI: 10.4081/monaldi.2024.2991
Amit Sharma, Deepak Rathi, Prerna Jain, Devika Tayal

Chronic obstructive pulmonary disease (COPD) presents as a multifaceted clinical landscape with various hematological manifestations. Among these, polycythemia and anemia pose distinct challenges. While the prevalence of polycythemia has decreased in recent years, anemia remains a prevalent concern, impacting patient outcomes. This study investigated the incidence and clinical characteristics of polycythemia in COPD patients, focusing on a diverse cohort in India. Methodological approaches included comprehensive evaluations of clinical parameters, pulmonary function, and hematological profiles. Results revealed significant variations in COPD severity, pulmonary function, and respiratory symptoms among patients with different hemoglobin levels. The findings shed light on the complex interplay between hematological variations and clinical manifestations in COPD, providing valuable insights for disease management strategies.

慢性阻塞性肺疾病(COPD)的临床表现多种多样,并伴有各种血液学表现。其中,多血细胞增多症和贫血构成了独特的挑战。虽然近年来多血细胞增多症的发病率有所下降,但贫血仍是一个普遍关注的问题,影响着患者的预后。本研究调查了慢性阻塞性肺病患者多血细胞增多症的发病率和临床特征,重点关注印度的不同人群。研究方法包括全面评估临床参数、肺功能和血液学特征。结果显示,不同血红蛋白水平的患者在慢性阻塞性肺病严重程度、肺功能和呼吸道症状方面存在明显差异。研究结果揭示了慢性阻塞性肺病血液学变异与临床表现之间复杂的相互作用,为疾病管理策略提供了宝贵的见解。
{"title":"Hematological and clinical profiling of chronic obstructive pulmonary disease: a comprehensive study.","authors":"Amit Sharma, Deepak Rathi, Prerna Jain, Devika Tayal","doi":"10.4081/monaldi.2024.2991","DOIUrl":"10.4081/monaldi.2024.2991","url":null,"abstract":"<p><p>Chronic obstructive pulmonary disease (COPD) presents as a multifaceted clinical landscape with various hematological manifestations. Among these, polycythemia and anemia pose distinct challenges. While the prevalence of polycythemia has decreased in recent years, anemia remains a prevalent concern, impacting patient outcomes. This study investigated the incidence and clinical characteristics of polycythemia in COPD patients, focusing on a diverse cohort in India. Methodological approaches included comprehensive evaluations of clinical parameters, pulmonary function, and hematological profiles. Results revealed significant variations in COPD severity, pulmonary function, and respiratory symptoms among patients with different hemoglobin levels. The findings shed light on the complex interplay between hematological variations and clinical manifestations in COPD, providing valuable insights for disease management strategies.</p>","PeriodicalId":51593,"journal":{"name":"Monaldi Archives for Chest Disease","volume":" ","pages":""},"PeriodicalIF":0.8,"publicationDate":"2025-10-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142332160","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Respiratory and physical therapy in the intensive care unit after liver transplantation for acute-on-chronic liver failure: a case report. 急性慢性肝功能衰竭肝移植术后重症监护病房的呼吸和物理治疗:病例报告。
IF 0.8 Q4 RESPIRATORY SYSTEM Pub Date : 2025-10-14 Epub Date: 2024-09-10 DOI: 10.4081/monaldi.2024.2898
Davide Tarello, Francesca Giogà, Andrea Lauterio, Chiara Becchetti, Giovanni Perricone, Giorgio Santi, Monica Ragazzi, Gianpaola Monti, Marta Lazzeri

Acute-on-chronic liver failure (ACLF) is a severe clinical condition for which liver transplantation (LT) is the only curative option. Due to the recipients' generally poor pre-operative clinical conditions and extensive surgery, post-LT respiratory disorders are very common and significantly contribute to related morbidity and mortality. We report the case of a 49-year-old patient with ACLF grade 3 who has been taken care of by the Respiratory Physiotherapy Team since hospital admission. After the extubation, the patient was supported with non-invasive ventilation and mechanical in-exsufflation; meanwhile, early resistance and functional training were started. No adverse events occurred during physiotherapy sessions, and the patient returned home without respiratory support. Respiratory and physical therapy in the intensive care unit after LT were safe and feasible interventions for this patient. Given the high incidence of postoperative pulmonary complications and the high rehabilitation needs, we suggest that physiotherapy should be provided for ACLF recipients.

急性慢性肝功能衰竭(ACLF)是一种严重的临床疾病,肝移植(LT)是唯一的治疗方案。由于受者术前的临床状况普遍较差,加之手术范围广泛,肝移植术后呼吸系统疾病非常常见,严重影响了相关的发病率和死亡率。我们报告了一例 49 岁的 ACLF 3 级患者,自入院以来一直由呼吸理疗小组照顾。拔管后,患者接受无创通气和机械通气支持,同时开始早期阻力和功能训练。物理治疗期间未发生任何不良事件,患者回家后也无需呼吸支持。对该患者来说,LT 术后在重症监护病房进行呼吸和物理治疗是安全可行的干预措施。鉴于术后肺部并发症的高发生率和高康复需求,我们建议为 ACLF 受术者提供物理治疗。
{"title":"Respiratory and physical therapy in the intensive care unit after liver transplantation for acute-on-chronic liver failure: a case report.","authors":"Davide Tarello, Francesca Giogà, Andrea Lauterio, Chiara Becchetti, Giovanni Perricone, Giorgio Santi, Monica Ragazzi, Gianpaola Monti, Marta Lazzeri","doi":"10.4081/monaldi.2024.2898","DOIUrl":"10.4081/monaldi.2024.2898","url":null,"abstract":"<p><p>Acute-on-chronic liver failure (ACLF) is a severe clinical condition for which liver transplantation (LT) is the only curative option. Due to the recipients' generally poor pre-operative clinical conditions and extensive surgery, post-LT respiratory disorders are very common and significantly contribute to related morbidity and mortality. We report the case of a 49-year-old patient with ACLF grade 3 who has been taken care of by the Respiratory Physiotherapy Team since hospital admission. After the extubation, the patient was supported with non-invasive ventilation and mechanical in-exsufflation; meanwhile, early resistance and functional training were started. No adverse events occurred during physiotherapy sessions, and the patient returned home without respiratory support. Respiratory and physical therapy in the intensive care unit after LT were safe and feasible interventions for this patient. Given the high incidence of postoperative pulmonary complications and the high rehabilitation needs, we suggest that physiotherapy should be provided for ACLF recipients.</p>","PeriodicalId":51593,"journal":{"name":"Monaldi Archives for Chest Disease","volume":" ","pages":""},"PeriodicalIF":0.8,"publicationDate":"2025-10-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142300533","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Aortic pseudoaneurysm with a fistula between the non-coronary sinus and right atrium: a case report. 主动脉假性动脉瘤伴非冠状窦和右心房之间的瘘管:病例报告。
IF 0.8 Q4 RESPIRATORY SYSTEM Pub Date : 2025-10-14 Epub Date: 2024-08-29 DOI: 10.4081/monaldi.2024.3039
Paolo Toritto, Elena Cescutti, Igor Vendramin, Michela Puppato, Massimo Imazio, Stefano De Carli, Olga Vriz

The authors present a case report of a 68-year-old man evaluated at the emergency department for repeated syncope, asthenia, and general malaise, suggesting heart failure in a patient with several comorbidities. At presentation, the patient was afebrile, but he had reported a low-grade fever in the previous 6 months. At first glance, transthoracic echocardiography was not clear, while transesophageal echocardiography revealed an echo-free image at the level of the non-coronary sinus of the aortic root, suggestive of a pseudoaneurysm communicating with the right atrium with continuous systo-diastolic flow, compatible with the aorto-cavitary fistula between the aortic root and the RA. Echocardiographic findings were confirmed by cardiac computed tomography. The case was discussed with the heart team and was considered suitable for surgery, but the patient suddenly died just before surgery due to impairment and friability.

作者报告了一例 68 岁男性患者的病例,该患者因反复晕厥、气喘和全身乏力而到急诊科就诊。就诊时,患者无发热,但此前六个月曾报告过低烧。乍一看,经胸超声心动图并不清晰,而经食道超声心动图显示主动脉根部非冠状动脉窦水平有无回声图像,提示假性动脉瘤,与右心房相通,有持续的收缩-舒张期血流,与主动脉根部和 RA 之间的主动脉空腔瘘相符。心脏计算机断层扫描证实了超声心动图结果。该病例经与心脏团队讨论后被认为适合手术,但患者在手术前因功能受损和易碎而突然死亡。
{"title":"Aortic pseudoaneurysm with a fistula between the non-coronary sinus and right atrium: a case report.","authors":"Paolo Toritto, Elena Cescutti, Igor Vendramin, Michela Puppato, Massimo Imazio, Stefano De Carli, Olga Vriz","doi":"10.4081/monaldi.2024.3039","DOIUrl":"10.4081/monaldi.2024.3039","url":null,"abstract":"<p><p>The authors present a case report of a 68-year-old man evaluated at the emergency department for repeated syncope, asthenia, and general malaise, suggesting heart failure in a patient with several comorbidities. At presentation, the patient was afebrile, but he had reported a low-grade fever in the previous 6 months. At first glance, transthoracic echocardiography was not clear, while transesophageal echocardiography revealed an echo-free image at the level of the non-coronary sinus of the aortic root, suggestive of a pseudoaneurysm communicating with the right atrium with continuous systo-diastolic flow, compatible with the aorto-cavitary fistula between the aortic root and the RA. Echocardiographic findings were confirmed by cardiac computed tomography. The case was discussed with the heart team and was considered suitable for surgery, but the patient suddenly died just before surgery due to impairment and friability.</p>","PeriodicalId":51593,"journal":{"name":"Monaldi Archives for Chest Disease","volume":" ","pages":""},"PeriodicalIF":0.8,"publicationDate":"2025-10-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142114614","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Role of GeneXpert in the diagnosis of extrapulmonary tuberculosis. GeneXpert 在诊断肺外结核病中的作用。
IF 0.8 Q4 RESPIRATORY SYSTEM Pub Date : 2025-10-14 Epub Date: 2024-07-25 DOI: 10.4081/monaldi.2024.2909
Unnati Desai, Saby Ak, Ketaki Utpat, Jyoti Bacche

The World Health Organization endorsed the cartridge-based nucleic acid amplification test Xpert MTB/RIF (GXP) for the diagnosis of tuberculosis (TB). Studies about GXP efficiency in extrapulmonary TB (EPTB) are scarce. Hence, we decided to study the role of GXP in EPTB. This prospective observational study, conducted in the pulmonary medicine department of a tertiary care hospital after ethics committee permission, recruited 200 EPTB patients. The diagnosis of TB was achieved with the help of clinico-radiological correlation with microbiological test positivity. Acid-fast bacilli (AFB) culture was treated as the comparative gold standard. Patients who had no or incomplete data were excluded from the study. Data were analyzed to calculate the sensitivity, specificity, positive predictive value, and negative predictive value for the diagnosis of TB and the detection of rifampicin resistance. The majority of cases were women (126 patients: 63%). The mean age was 23.71 years. On GXP, 130 (65%) had detected Mycobacterium tuberculosis, and 70 (35%) did not. Adding AFB culture data, 168 (81.5%) showed microbiological evidence of TB, and 32 (18.5%) were negative. On the drug susceptibility test, 131 cases were rifampicin-sensitive, 32 were rifampicin-resistant TB, and in 5 cases, data were unavailable. The most common extrapulmonary site of involvement was the lymph node, with 94 patients (47%). The most common lymph node involved was the cervical lymph node, with 70 patients (74.5%). The sensitivity, specificity, positive predictive value, and negative predictive value of GXP in EPTB collectively were 76.68%, 86.48%, 96%, and 45.7%, respectively. GXP is useful for the rapid detection of EPTB and the identification of rifampicin resistance, especially in a high-prevalence country like India.

世界卫生组织批准将盒式核酸扩增检验 Xpert MTB/RIF(GXP)用于结核病(TB)诊断。有关 GXP 在肺外结核病(EPTB)中效率的研究很少。因此,我们决定研究 GXP 在 EPTB 中的作用。这项前瞻性观察研究是在一家三级医院的肺内科进行的,经过伦理委员会批准,共招募了 200 名 EPTB 患者。肺结核的诊断是通过临床放射学与微生物检验阳性的相关性来实现的。酸性无菌杆菌(AFB)培养被视为比较金标准。没有数据或数据不完整的患者被排除在研究之外。通过对数据进行分析,计算出肺结核诊断和利福平耐药性检测的灵敏度、特异性、阳性预测值和阴性预测值。大多数病例为女性(126 名患者:63%)。平均年龄为 23.71 岁。在 GXP 检测中,130 人(65%)检测出结核分枝杆菌(MTB),70 人(35%)未检测出。加上 AFB 培养数据,168 人(81.5%)有结核病微生物学证据,32 人(18.5%)为阴性。在药敏试验中,131 例为利福平敏感型肺结核,32 例为利福平耐药型肺结核,5 例无数据。最常见的肺外受累部位是淋巴结,有 94 名患者(47%)。最常见的受累淋巴结是颈淋巴结,有 70 名患者(74.5%)。GXP 对 EPTB 的敏感性、特异性、阳性预测值和阴性预测值分别为 76.68%、86.48%、96% 和 45.7%。GXP 可用于快速检测 EPTB 和鉴定利福平耐药性,尤其是在印度这样的高发病率国家。
{"title":"Role of GeneXpert in the diagnosis of extrapulmonary tuberculosis.","authors":"Unnati Desai, Saby Ak, Ketaki Utpat, Jyoti Bacche","doi":"10.4081/monaldi.2024.2909","DOIUrl":"10.4081/monaldi.2024.2909","url":null,"abstract":"<p><p>The World Health Organization endorsed the cartridge-based nucleic acid amplification test Xpert MTB/RIF (GXP) for the diagnosis of tuberculosis (TB). Studies about GXP efficiency in extrapulmonary TB (EPTB) are scarce. Hence, we decided to study the role of GXP in EPTB. This prospective observational study, conducted in the pulmonary medicine department of a tertiary care hospital after ethics committee permission, recruited 200 EPTB patients. The diagnosis of TB was achieved with the help of clinico-radiological correlation with microbiological test positivity. Acid-fast bacilli (AFB) culture was treated as the comparative gold standard. Patients who had no or incomplete data were excluded from the study. Data were analyzed to calculate the sensitivity, specificity, positive predictive value, and negative predictive value for the diagnosis of TB and the detection of rifampicin resistance. The majority of cases were women (126 patients: 63%). The mean age was 23.71 years. On GXP, 130 (65%) had detected Mycobacterium tuberculosis, and 70 (35%) did not. Adding AFB culture data, 168 (81.5%) showed microbiological evidence of TB, and 32 (18.5%) were negative. On the drug susceptibility test, 131 cases were rifampicin-sensitive, 32 were rifampicin-resistant TB, and in 5 cases, data were unavailable. The most common extrapulmonary site of involvement was the lymph node, with 94 patients (47%). The most common lymph node involved was the cervical lymph node, with 70 patients (74.5%). The sensitivity, specificity, positive predictive value, and negative predictive value of GXP in EPTB collectively were 76.68%, 86.48%, 96%, and 45.7%, respectively. GXP is useful for the rapid detection of EPTB and the identification of rifampicin resistance, especially in a high-prevalence country like India.</p>","PeriodicalId":51593,"journal":{"name":"Monaldi Archives for Chest Disease","volume":" ","pages":""},"PeriodicalIF":0.8,"publicationDate":"2025-10-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141762533","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
A decade's summary of transcatheter tricuspid valve repair. 经导管三尖瓣修复术十年总结。
IF 0.8 Q4 RESPIRATORY SYSTEM Pub Date : 2025-10-14 Epub Date: 2024-07-25 DOI: 10.4081/monaldi.2024.3029
Aladdin Bashir, Zaheer Tahir, Mahmood Ahmad, Kyriacos Mouyis, Ali Zuhair Kirresh, Sameh Atta, Clinton Lloyd, Malcolm Dalrymple-Hay

Tricuspid regurgitation (TR) is the most common pathology of the tricuspid valve. Moderate to severe TR is associated with morbidity and adverse outcomes. The concept that TR resolves on its own if the underlying disease is successfully treated has proven to be false. Only a few patients with significant TR are deemed suitable for surgery. Given the late presentation of patients with high perioperative risks and substantial perioperative mortality, the development of transcatheter therapies and the experience gained with transcatheter aortic valve implantation operations have turned attention towards treating this challenging group of patients. In this article, we review the treatment options and highlight the role of transcatheter valve therapies in patients with severe TR.

三尖瓣反流(TR)是三尖瓣最常见的病变。中度至重度三尖瓣反流与发病率和不良预后有关。事实证明,"只要成功治疗潜在疾病,TR 就会自行缓解 "的观点是错误的。只有少数严重 TR 患者被认为适合手术治疗。由于患者发病较晚,围术期风险较高,围术期死亡率较高,经导管疗法的开发和经导管主动脉瓣植入手术的经验使人们将注意力转向了治疗这类具有挑战性的患者。在本文中,我们回顾了治疗方案,并强调了经导管瓣膜疗法在重度 TR 患者中的作用。
{"title":"A decade's summary of transcatheter tricuspid valve repair.","authors":"Aladdin Bashir, Zaheer Tahir, Mahmood Ahmad, Kyriacos Mouyis, Ali Zuhair Kirresh, Sameh Atta, Clinton Lloyd, Malcolm Dalrymple-Hay","doi":"10.4081/monaldi.2024.3029","DOIUrl":"10.4081/monaldi.2024.3029","url":null,"abstract":"<p><p>Tricuspid regurgitation (TR) is the most common pathology of the tricuspid valve. Moderate to severe TR is associated with morbidity and adverse outcomes. The concept that TR resolves on its own if the underlying disease is successfully treated has proven to be false. Only a few patients with significant TR are deemed suitable for surgery. Given the late presentation of patients with high perioperative risks and substantial perioperative mortality, the development of transcatheter therapies and the experience gained with transcatheter aortic valve implantation operations have turned attention towards treating this challenging group of patients. In this article, we review the treatment options and highlight the role of transcatheter valve therapies in patients with severe TR.</p>","PeriodicalId":51593,"journal":{"name":"Monaldi Archives for Chest Disease","volume":" ","pages":""},"PeriodicalIF":0.8,"publicationDate":"2025-10-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141762526","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Reduction of inappropriate shock rate through signal filtering (smart-pass) in patients with implantable subcutaneous cardioverter-defibrillator: a systematic review and meta-analysis. 通过信号滤波(智能滤波)降低植入式皮下心律转复除颤器患者的不当电击率:系统综述和荟萃分析。
IF 0.8 Q4 RESPIRATORY SYSTEM Pub Date : 2025-10-14 Epub Date: 2024-08-29 DOI: 10.4081/monaldi.2024.3013
Maurizio Santomauro, Mario Petretta, Carla Riganti, Mario Alberto Santomauro, Mariarosaria De Luca, Andrea Santomauro, Antonio Cittadini

Subcutaneous implantable cardioverter-defibrillators (S-ICD) are effective in protecting patients against sudden death but expose them to a higher risk of inappropriate shock (IAS). We performed a systematic search of studies published between January 2010 and December 2019 assessing IAS due to cardiac oversensing by the selection process (PRISMA) and identified 17 eligible articles. A total of 15 studies were observational, and 2 were retrospective. For the meta-analysis, the final population included 6111 patients: 3356 without the SMART-pass (SP) filter (group 1) and 2755 with the SP filter (group 2). A total of 1614 shocks (appropriate shocks plus IAS) were registered (1245 in group 1 and 369 in group 2). The random effects meta-analysis estimated an overall IAS rate of 7.78% (95% confidence interval: 4.93-10.64) with substantial variability between studies (I2=96.05%, p<0.001). The IAS rate was 10.75% (95% confidence interval: 8.49-13.02) for group 1 and 3.61% (95% confidence interval: 1.36-5.86) for group 2 (p<0.001). Third-generation S-ICD technology with SP filters reduced the risk of cardiac signal-related IAS.

皮下植入式心律转复除颤器(S-ICD)可有效保护患者免于猝死,但却使患者面临更高的不适当休克(IAS)风险。我们对 2010 年 1 月至 2019 年 12 月间发表的研究进行了系统性检索,通过筛选过程(PRISMA)评估了心脏超感引起的 IAS,并确定了 17 篇符合条件的文章。其中 15 篇为观察性研究,2 篇为回顾性研究。荟萃分析的最终研究对象包括 6111 名患者:3356名患者未使用SMART通过(SP)过滤器(第1组),2755名患者使用SP过滤器(第2组)。共登记了 1614 次冲击(适当冲击加 IAS)(第一组 1245 次,第二组 369 次)。随机效应荟萃分析估计总体 IAS 率为 7.78%(95% 置信区间:4.93-10.64),不同研究之间存在很大差异(I 平方=96.05%,p
{"title":"Reduction of inappropriate shock rate through signal filtering (smart-pass) in patients with implantable subcutaneous cardioverter-defibrillator: a systematic review and meta-analysis.","authors":"Maurizio Santomauro, Mario Petretta, Carla Riganti, Mario Alberto Santomauro, Mariarosaria De Luca, Andrea Santomauro, Antonio Cittadini","doi":"10.4081/monaldi.2024.3013","DOIUrl":"10.4081/monaldi.2024.3013","url":null,"abstract":"<p><p>Subcutaneous implantable cardioverter-defibrillators (S-ICD) are effective in protecting patients against sudden death but expose them to a higher risk of inappropriate shock (IAS). We performed a systematic search of studies published between January 2010 and December 2019 assessing IAS due to cardiac oversensing by the selection process (PRISMA) and identified 17 eligible articles. A total of 15 studies were observational, and 2 were retrospective. For the meta-analysis, the final population included 6111 patients: 3356 without the SMART-pass (SP) filter (group 1) and 2755 with the SP filter (group 2). A total of 1614 shocks (appropriate shocks plus IAS) were registered (1245 in group 1 and 369 in group 2). The random effects meta-analysis estimated an overall IAS rate of 7.78% (95% confidence interval: 4.93-10.64) with substantial variability between studies (I2=96.05%, p<0.001). The IAS rate was 10.75% (95% confidence interval: 8.49-13.02) for group 1 and 3.61% (95% confidence interval: 1.36-5.86) for group 2 (p<0.001). Third-generation S-ICD technology with SP filters reduced the risk of cardiac signal-related IAS.</p>","PeriodicalId":51593,"journal":{"name":"Monaldi Archives for Chest Disease","volume":" ","pages":""},"PeriodicalIF":0.8,"publicationDate":"2025-10-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142114631","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Evaluation of end-tidal carbon dioxide as a marker of fluid responsiveness in mechanically ventilated patients with shock: a prospective study in a tertiary care center in India. 评估潮末二氧化碳作为机械通气休克患者液体反应性的标志:印度三级保健中心的一项前瞻性研究
IF 0.8 Q4 RESPIRATORY SYSTEM Pub Date : 2025-10-14 DOI: 10.4081/monaldi.2025.3387
Ganesh Narwade, Shibdas Chakrabarti, Rajnish Kaushik, Rohit Kumar, Neeraj Gupta, Nitesh Gupta, Pranav Ish, Manu Madan, Mahendran Aj, Tanmaya Talukdar

Shock management in intensive care unit (ICU) patients requires accurate assessment of fluid responsiveness to optimize outcomes. Dynamic indices, such as passive leg raising (PLR), are often underutilized due to invasive or complex techniques. Our aim was to evaluate change in end-tidal carbon dioxide (EtCO₂) during PLR as a non-invasive dynamic index of fluid responsiveness in mechanically ventilated ICU patients with shock. This was a prospective, observational cohort study conducted in a respiratory ICU at a tertiary care center in New Delhi, India. The study recruited adult patients on mechanical ventilation with shock between November 2022 and April 2024. After screening 340 ICU admissions during the recruitment period for inclusions and exclusions, a total of 90 adult patients on mechanical ventilation with shock were enrolled in the study. Measurements of EtCO₂ via mainstream capnography and cardiac output (CO) with transthoracic echocardiography (TTE) were done pre- and post-PLR. Fluid responsiveness was defined as a ≥10% increase in CO measured via TTE following PLR. Simultaneously, EtCO₂ was measured, with a ≥5% increase considered predictive of fluid responsiveness. Sensitivity, specificity, and the area under the receiver operating characteristic curve (AUROC) were calculated for EtCO₂. The study found a sensitivity of 86.8% and specificity of 88.5% for a ≥5% increase in EtCO₂, with an AUROC of 0.951, indicating high diagnostic accuracy. A significant correlation was observed between EtCO₂ changes and fluid responsiveness, validating EtCO₂ as a reliable predictor comparable to TTE. To conclude, EtCO₂ monitoring during PLR is a practical, non-invasive tool for assessing fluid responsiveness in ICU patients with shock. This method is suitable for bedside application, particularly in resource-limited settings, and supports informed fluid management decisions. Further multicenter studies are recommended to confirm its broader applicability.

重症监护病房(ICU)患者的休克管理需要准确评估液体反应以优化结果。动态指标,如被动抬腿(PLR),往往由于侵入性或复杂的技术而未得到充分利用。我们的目的是评估PLR期间末潮二氧化碳(EtCO₂)的变化,作为机械通气ICU休克患者液体反应性的无创动态指标。这是一项前瞻性、观察性队列研究,在印度新德里一家三级护理中心的呼吸ICU进行。该研究招募了2022年11月至2024年4月期间使用机械通气的休克成年患者。在招募期间对340例ICU入院患者进行纳入和排除后,共纳入90例机械通气合并休克的成年患者。在plr前后分别通过主流血管造影和经胸超声心动图(TTE)测量EtCO₂和心输出量(CO)。液体反应性定义为在PLR后通过TTE测量的CO增加≥10%。同时,测量EtCO₂,升高≥5%可预测流体响应性。计算EtCO₂的灵敏度、特异度和受试者工作特征曲线下面积(AUROC)。研究发现,EtCO₂升高≥5%的敏感性为86.8%,特异性为88.5%,AUROC为0.951,诊断准确率较高。观察到EtCO₂变化与流体响应性之间存在显著相关性,验证了EtCO₂是与TTE相当的可靠预测因子。综上所述,在PLR期间监测EtCO₂是一种实用的、无创的评估ICU休克患者液体反应性的工具。该方法适用于床边应用,特别是在资源有限的环境中,并支持明智的流体管理决策。建议进一步的多中心研究以证实其更广泛的适用性。
{"title":"Evaluation of end-tidal carbon dioxide as a marker of fluid responsiveness in mechanically ventilated patients with shock: a prospective study in a tertiary care center in India.","authors":"Ganesh Narwade, Shibdas Chakrabarti, Rajnish Kaushik, Rohit Kumar, Neeraj Gupta, Nitesh Gupta, Pranav Ish, Manu Madan, Mahendran Aj, Tanmaya Talukdar","doi":"10.4081/monaldi.2025.3387","DOIUrl":"https://doi.org/10.4081/monaldi.2025.3387","url":null,"abstract":"<p><p>Shock management in intensive care unit (ICU) patients requires accurate assessment of fluid responsiveness to optimize outcomes. Dynamic indices, such as passive leg raising (PLR), are often underutilized due to invasive or complex techniques. Our aim was to evaluate change in end-tidal carbon dioxide (EtCO₂) during PLR as a non-invasive dynamic index of fluid responsiveness in mechanically ventilated ICU patients with shock. This was a prospective, observational cohort study conducted in a respiratory ICU at a tertiary care center in New Delhi, India. The study recruited adult patients on mechanical ventilation with shock between November 2022 and April 2024. After screening 340 ICU admissions during the recruitment period for inclusions and exclusions, a total of 90 adult patients on mechanical ventilation with shock were enrolled in the study. Measurements of EtCO₂ via mainstream capnography and cardiac output (CO) with transthoracic echocardiography (TTE) were done pre- and post-PLR. Fluid responsiveness was defined as a ≥10% increase in CO measured via TTE following PLR. Simultaneously, EtCO₂ was measured, with a ≥5% increase considered predictive of fluid responsiveness. Sensitivity, specificity, and the area under the receiver operating characteristic curve (AUROC) were calculated for EtCO₂. The study found a sensitivity of 86.8% and specificity of 88.5% for a ≥5% increase in EtCO₂, with an AUROC of 0.951, indicating high diagnostic accuracy. A significant correlation was observed between EtCO₂ changes and fluid responsiveness, validating EtCO₂ as a reliable predictor comparable to TTE. To conclude, EtCO₂ monitoring during PLR is a practical, non-invasive tool for assessing fluid responsiveness in ICU patients with shock. This method is suitable for bedside application, particularly in resource-limited settings, and supports informed fluid management decisions. Further multicenter studies are recommended to confirm its broader applicability.</p>","PeriodicalId":51593,"journal":{"name":"Monaldi Archives for Chest Disease","volume":" ","pages":""},"PeriodicalIF":0.8,"publicationDate":"2025-10-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145304327","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
SARS-CoV-2 JN.1 variant: a short review. SARS-CoV-2 JN.1 变异体:简短回顾。
IF 0.8 Q4 RESPIRATORY SYSTEM Pub Date : 2025-10-14 Epub Date: 2024-08-30 DOI: 10.4081/monaldi.2024.2981
Sarkar Malay, Irappa V Madabhavi, Anurag Tripathi

The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is a single-stranded, positive-sense RNA virus. The SARS-CoV-2 virus is evolving continuously, and many variants have been detected over the last few years. SARS-CoV-2, as an RNA virus, is more prone to mutating. The continuous evolution of the SARS-CoV-2 virus is due to genetic mutation and recombination during the genomic replication process. Recombination is a naturally occurring phenomenon in which two distinct viral lineages simultaneously infect the same cellular entity in an individual. The evolution rate depends on the rate of mutation. The rate of mutation is variable among the RNA viruses, with the SARS-CoV-2 virus exhibiting a lower rate of mutation than other RNA viruses. The novel 3'-to-5' exoribonuclease proofreading machinery is responsible for a lower rate of mutation. Infections due to SARS-CoV-2, influenza, and respiratory syncytial virus have been reported from around the world during the same period of fall and winter, resulting in a "tripledemic". The JN.1 variant, which evolved from the predecessor, the Omicron variant BA.2.86, is currently the most dominant globally. The impact of the JN.1 variant on transmissibility, disease severity, immune evasion, and diagnostic and therapeutic escape will be discussed.

严重急性呼吸系统综合症冠状病毒 2(SARS-CoV-2)是一种单链正义 RNA 病毒。SARS-CoV-2 病毒在不断进化,在过去几年中发现了许多变种。作为一种 RNA 病毒,SARS-CoV-2 更容易发生变异。SARS-CoV-2 病毒不断进化的原因是基因组复制过程中的基因突变和重组。重组是一种自然发生的现象,即两个不同的病毒系同时感染一个人的同一个细胞实体。进化速度取决于突变速度。RNA 病毒的变异率各不相同,SARS-CoV-2 病毒的变异率低于其他 RNA 病毒。新型 3'-to-5'exoribonuclease 校对机制是变异率较低的原因。据报道,在同一秋冬季节,世界各地都出现了由 SARS-CoV-2、流感和呼吸道合胞病毒引起的感染,造成了 "三重流行"。JN.1变种是由其前身奥米克变种BA.2.86演变而来,目前在全球范围内占最主要地位。本文将讨论 JN.1 变体对传播性、疾病严重程度、免疫逃避以及诊断和治疗逃逸的影响。
{"title":"SARS-CoV-2 JN.1 variant: a short review.","authors":"Sarkar Malay, Irappa V Madabhavi, Anurag Tripathi","doi":"10.4081/monaldi.2024.2981","DOIUrl":"10.4081/monaldi.2024.2981","url":null,"abstract":"<p><p>The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is a single-stranded, positive-sense RNA virus. The SARS-CoV-2 virus is evolving continuously, and many variants have been detected over the last few years. SARS-CoV-2, as an RNA virus, is more prone to mutating. The continuous evolution of the SARS-CoV-2 virus is due to genetic mutation and recombination during the genomic replication process. Recombination is a naturally occurring phenomenon in which two distinct viral lineages simultaneously infect the same cellular entity in an individual. The evolution rate depends on the rate of mutation. The rate of mutation is variable among the RNA viruses, with the SARS-CoV-2 virus exhibiting a lower rate of mutation than other RNA viruses. The novel 3'-to-5' exoribonuclease proofreading machinery is responsible for a lower rate of mutation. Infections due to SARS-CoV-2, influenza, and respiratory syncytial virus have been reported from around the world during the same period of fall and winter, resulting in a \"tripledemic\". The JN.1 variant, which evolved from the predecessor, the Omicron variant BA.2.86, is currently the most dominant globally. The impact of the JN.1 variant on transmissibility, disease severity, immune evasion, and diagnostic and therapeutic escape will be discussed.</p>","PeriodicalId":51593,"journal":{"name":"Monaldi Archives for Chest Disease","volume":" ","pages":""},"PeriodicalIF":0.8,"publicationDate":"2025-10-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142114632","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
An incidental finding of localized aortic arch dissection in a polytraumatized patient. A case report and state of the art of non-A non-B aortic dissection. 一名多发性创伤患者偶然发现的局部主动脉弓夹层。非A型非B型主动脉夹层的病例报告和技术现状。
IF 0.8 Q4 RESPIRATORY SYSTEM Pub Date : 2025-10-14 Epub Date: 2024-09-12 DOI: 10.4081/monaldi.2024.2986
Andrea Giovanni Parato, Simone D'Agostino, Simona Pelliccioni, Maria Virginia Boni, Andrea Angelini, Francesco Sbaraglia, Vito Maurizio Parato

Non-A non-B aortic dissection is considered a rare nosological entity, included in the Stanford classification, representing a small percentage of the total aortic dissections that occur annually. Regarding this form, the literature reports a more complicated disease course compared to other types of dissection. We describe the case of a 76-year-old patient who accessed the triage section of an emergency department for a polytrauma picture and, after surgical treatment of a leg fracture, received a diagnosis of non-A non-B aortic dissection, "localized" to the arch and incidentally detected. The angio-computed tomography (CT) showed that the only intimal tear was located in the central portion of the aortic arch, with no exit tear. No signs of malperfusion or clinical symptoms related to the aortic finding were evident. The Aortic Team decided on a conservative approach, whereby the patient was started on medical therapy to control blood pressure in a monitored bed of a semi-intensive care unit. The persistent asymptomatic state, a condition of hemodynamic stability, and an unchanged angio-CT picture enabled discharge on day 7 and the assignment to a close follow-up.

非 A 非 B 型主动脉夹层被认为是一种罕见的命名实体,已被纳入斯坦福分类法,在每年发生的主动脉夹层总数中只占很小的比例。与其他类型的主动脉夹层相比,文献报道这种主动脉夹层的病程更为复杂。我们描述了一例 76 岁患者的病例,他因多发性创伤就诊于急诊科分诊区,在接受腿部骨折手术治疗后,被诊断为非 A 非 B 主动脉夹层,"局部 "位于弓部,是偶然发现的。血管计算机断层扫描(CT)显示,唯一的内膜撕裂位于主动脉弓的中央部分,没有出口撕裂。没有明显的灌注不良迹象,也没有与主动脉发现相关的临床症状。主动脉小组决定采取保守疗法,在半重症监护病房的监护床上开始对患者进行药物治疗以控制血压。由于患者持续无症状、血液动力学状况稳定、血管 CT 图像无变化,因此患者在第 7 天就可以出院,并接受密切随访。
{"title":"An incidental finding of localized aortic arch dissection in a polytraumatized patient. A case report and state of the art of <i>non-A non-B</i> aortic dissection.","authors":"Andrea Giovanni Parato, Simone D'Agostino, Simona Pelliccioni, Maria Virginia Boni, Andrea Angelini, Francesco Sbaraglia, Vito Maurizio Parato","doi":"10.4081/monaldi.2024.2986","DOIUrl":"10.4081/monaldi.2024.2986","url":null,"abstract":"<p><p>Non-A non-B aortic dissection is considered a rare nosological entity, included in the Stanford classification, representing a small percentage of the total aortic dissections that occur annually. Regarding this form, the literature reports a more complicated disease course compared to other types of dissection. We describe the case of a 76-year-old patient who accessed the triage section of an emergency department for a polytrauma picture and, after surgical treatment of a leg fracture, received a diagnosis of non-A non-B aortic dissection, \"localized\" to the arch and incidentally detected. The angio-computed tomography (CT) showed that the only intimal tear was located in the central portion of the aortic arch, with no exit tear. No signs of malperfusion or clinical symptoms related to the aortic finding were evident. The Aortic Team decided on a conservative approach, whereby the patient was started on medical therapy to control blood pressure in a monitored bed of a semi-intensive care unit. The persistent asymptomatic state, a condition of hemodynamic stability, and an unchanged angio-CT picture enabled discharge on day 7 and the assignment to a close follow-up.</p>","PeriodicalId":51593,"journal":{"name":"Monaldi Archives for Chest Disease","volume":" ","pages":""},"PeriodicalIF":0.8,"publicationDate":"2025-10-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142300523","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Exploring the role of Aspergillus galactomannan antigen in assessing the risk factor of acute exacerbations in chronic obstructive pulmonary disease patients: a cross-sectional study. 探索曲霉半乳甘露聚糖抗原在评估慢性阻塞性肺病患者急性加重风险因素中的作用:一项横断面研究。
IF 0.8 Q4 RESPIRATORY SYSTEM Pub Date : 2025-10-14 Epub Date: 2024-09-12 DOI: 10.4081/monaldi.2024.3041
Jayabharathi Palanivel, Madhusmita Mohanty Mohapatra, Manju Rajaram, Debasis Gochhait, Sunitha Vellathussery Chakkalakkoombil, Rakesh Singh

Chronic obstructive pulmonary disease (COPD) is characterized by permanent airflow obstruction due to abnormalities of the airways and alveoli. This study investigated the potential role of Aspergillus species in acute exacerbations of COPD (AE-COPD) and evaluated the diagnostic utility of serum Aspergillus galactomannan antigen. This cross-sectional study, carried out at the Jawaharlal Institute of Postgraduate Medical Education and Research from January 2021 to June 2022, involved COPD patients aged ≥40 years. Serum galactomannan and serum Aspergillus-specific antibodies were analyzed, along with the collection of demographic details, symptoms, and comorbidities. Statistical analyses, including univariate analysis and receiver operating characteristic (ROC) curve analysis, were performed. Among the 61 recruited COPD patients, 24.5% showed serum galactomannan positivity. Significant associations were found between galactomannan positivity, hemoptysis, and previous tuberculosis. ROC analysis revealed modest diagnostic accuracy (area under the ROC=0.6027) with a sensitivity of 44.4% and a specificity of 83.7% at a cut-off of 0.5. Univariate analysis did not show any potential links between diabetes, hypertension, previous exacerbations, and severe Global Initiative for Chronic Obstructive Lung Disease stages with a risk of exacerbation. Serum galactomannan antigen showed limited sensitivity, and its routine testing may not be justified for predicting exacerbation risk. Further studies are warranted to validate these findings and explore other diagnostic methods using bronchoalveolar lavage galactomannan antigen in AE-COPD.

慢性阻塞性肺疾病(COPD)的特点是由于气道和肺泡异常导致永久性气流阻塞。本研究调查了曲霉菌在慢性阻塞性肺病急性加重(AECOPD)中的潜在作用,并评估了血清曲霉菌半乳甘露聚糖抗原的诊断效用。这项横断面研究于 2021 年 1 月至 2022 年 6 月在贾瓦哈拉尔研究生医学教育与研究院(Jawaharlal Institute of Postgraduate Medical Education and Research)进行,涉及年龄≥40 岁的慢性阻塞性肺病患者。研究分析了血清半乳甘露聚糖和血清曲霉菌特异性抗体,并收集了人口统计学细节、症状和合并症。统计分析包括单变量分析和接收器操作特征曲线(ROC)分析。在招募的 61 名慢性阻塞性肺病患者中,24.5% 的患者血清半乳甘露聚糖呈阳性。半乳甘露聚糖阳性、咯血和既往肺结核之间存在显著关联。ROC分析显示诊断准确性不高(ROC下面积=0.6027),以0.5为临界值,灵敏度为44.4%,特异度为83.7%。单变量分析未显示糖尿病、高血压、既往病情恶化和重度金色阶段与病情恶化风险之间存在任何潜在联系。血清半乳甘露聚糖抗原的灵敏度有限,常规检测可能不足以预测病情恶化的风险。有必要开展进一步的研究来验证这些发现,并探索在 AECOPD 中使用支气管肺泡灌洗液半乳甘露聚糖抗原的其他诊断方法。
{"title":"Exploring the role of Aspergillus galactomannan antigen in assessing the risk factor of acute exacerbations in chronic obstructive pulmonary disease patients: a cross-sectional study.","authors":"Jayabharathi Palanivel, Madhusmita Mohanty Mohapatra, Manju Rajaram, Debasis Gochhait, Sunitha Vellathussery Chakkalakkoombil, Rakesh Singh","doi":"10.4081/monaldi.2024.3041","DOIUrl":"10.4081/monaldi.2024.3041","url":null,"abstract":"<p><p>Chronic obstructive pulmonary disease (COPD) is characterized by permanent airflow obstruction due to abnormalities of the airways and alveoli. This study investigated the potential role of Aspergillus species in acute exacerbations of COPD (AE-COPD) and evaluated the diagnostic utility of serum Aspergillus galactomannan antigen. This cross-sectional study, carried out at the Jawaharlal Institute of Postgraduate Medical Education and Research from January 2021 to June 2022, involved COPD patients aged ≥40 years. Serum galactomannan and serum Aspergillus-specific antibodies were analyzed, along with the collection of demographic details, symptoms, and comorbidities. Statistical analyses, including univariate analysis and receiver operating characteristic (ROC) curve analysis, were performed. Among the 61 recruited COPD patients, 24.5% showed serum galactomannan positivity. Significant associations were found between galactomannan positivity, hemoptysis, and previous tuberculosis. ROC analysis revealed modest diagnostic accuracy (area under the ROC=0.6027) with a sensitivity of 44.4% and a specificity of 83.7% at a cut-off of 0.5. Univariate analysis did not show any potential links between diabetes, hypertension, previous exacerbations, and severe Global Initiative for Chronic Obstructive Lung Disease stages with a risk of exacerbation. Serum galactomannan antigen showed limited sensitivity, and its routine testing may not be justified for predicting exacerbation risk. Further studies are warranted to validate these findings and explore other diagnostic methods using bronchoalveolar lavage galactomannan antigen in AE-COPD.</p>","PeriodicalId":51593,"journal":{"name":"Monaldi Archives for Chest Disease","volume":" ","pages":""},"PeriodicalIF":0.8,"publicationDate":"2025-10-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142300525","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Monaldi Archives for Chest Disease
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1